Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for January 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

UK industry seizes initiative to head off call for new laws
ABPI makes recommendations..(more)

 MHRA admits to shortcomings
MHRA chairman questioned..(more)

 Lilly takes on BMJ over Prozac claims
Lilly goes on offensive..(more)

 Breakthrough cancer drug Avastin approved
Roche drug approved in Europe..(more)

 Text messages and e-mails to help spread health message
Self care a key initiative ..(more)

 Plavix leads the way in UK sales growth
UK sales fastest growing..(more)

 FDA blocks self-diagnosis over-the-counter statin Mevacor
Patient risk unacceptable..(more)

 AstraZeneca looks to oncology pipeline after failure of Iressa
Boost for Tarceva..(more)

 Pfizer survey shows UK patients want greater information
UK patients know more..(more)

 Antisoma acquires exciting new anti-cancer drug
Exciting drug unearthed..(more)

 Med comms veteran launches Acumen
Variety of services offered..(more)

 UK industry code of practice to be reviewed
New code targeted for end of 2005..(more)

 Global industry commits to new data openness
Leading bodies aim for consensus..(more)

 Industry contributes to disaster relief in Asia
Money and medicines donated..(more)

 Community matrons to manage chronic disease
NHS creates new role..(more)

 Advert exaggerated Plavix benefits
Co-marketers defend ad..(more)

 Personalised medicine moves a step closer
New test developed..(more)

 Avandia advert hypertension claims 'misleading'
GSK breaks Code rules..(more)

 Yamanouchi to launch prostate cancer drug Eligard
Drug approved across Europe..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.